Login
$RPRX
$68.19 -$0.34 (0.49%) After hours

$RPRX 8-K/A SEC Filings

Filed On Filing
03 Aug 2020 8-K/A: Departure/Election of Directors or Officers; Compensation

As previously reported on a Current Report on Form 8-K filed by Royalty Pharma plc (the “Company”) on June 16, 2020 (the “Form 8-K”), the Company’s Board of Directors (the “Board”) appointed Catherine Engelbert as a member of the Board. ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support